Abstract
Germline missense mutations in GJB2 encoding connexin (Cx) 26 have been found in keratitis, ichthyosis and deafness (KID) syndrome. We explored the effects of three mouse Cx26 mutants (Cx26-G12R, -G45E and -D50N) corresponding to KID syndrome-causative human mutants on hemichannel activities leading to cell death and the expression of immune response-associated genes. We analyzed the 3D images of cells expressing wild-type (WT) or mutant Cx26 molecules to demonstrate clearly the intracellular localization of Cx26 mutants and hemichannel formation. High extracellular Ca2+ conditions lead to the closure of gap junction hemichannels in Cx26-G12R or Cx26-G45E expressing cells, resulting in prohibition of the Cx26 mutant-induced cell death. Fluorescent dye uptake assays revealed that cells with Cx26-D50N had aberrantly high hemichannel activities, which were abolished by a hemichannel blocker, carbenoxolone and 18α-Glycyrrhetinic acid. These results further support the idea that abnormal hemichannel activities play important roles in the pathogenesis of KID syndrome. Furthermore, we revealed that the expressions of IL15, CCL5, IL1A, IL23R and TLR5 are down-regulated in keratinocytes expressing Cx26-D50N, suggesting that immune deficiency in KID syndrome expressing Cx26-D50N might be associated not only with skin barrier defects, but also with the down-regulated expression of immune response-related genes.
Similar content being viewed by others
Introduction
Keratitis, ichthyosis and deafness (KID) syndrome is named for its clinical triad of erythrokeratoderma, vascularizing keratitis and bilateral sensorineural hearing loss. The syndrome was first recognized as a distinct clinical entity by Skinner et al. in 19811. Although KID syndrome is rare, the cutaneous and extracutaneous manifestations of the disease are profoundly serious and refractory to treatment2. Patients with KID syndrome often present with extensive skin involvement and are at high risk for cutaneous bacterial infection3. Nearly half of patients with KID syndrome have an episode of chronic skin infection4. Skin tumors, particularly trichilemmal tumors and squamous cell carcinoma (SCC), are common during the disease course5. Indeed, about 15% of KID syndrome patients are reported to develop SCC of the skin and the oral mucosa6. Germline missense mutations in GJB2 encoding connexin (Cx) 26 have been found to be associated with KID syndrome7. Cxs are membrane proteins that are primarily involved in intercellular communication. They are synthesized in the endoplasmic reticulum (ER)-Golgi network, and six Cx molecules are oligomerized to form a connexon (hemichannel), which docks at cell–cell contact points to form a gap junction intercellular channel that allows exchanges of electrical signals and biochemically important molecules between neighboring cells. Hemichannels allow cells to communicate with the extracellular environment8,9,10,11,12,13. Although the causative genetic defect of KID syndrome has been identified7, the molecular mechanisms that lead to the skin phenotypes via dysfunction of gap junctions and/or aberrant functions of hemichannels are poorly understood14. Various experiments have shown that KID syndrome-causative GJB2 mutations result in the formation of Cx26 hemichannels with aberrant activity15,16,17,18,19,20,21,22,23. However, the results of these experiments have not always been consistent. Even for an identical GJB2 mutation, some reports have revealed that cell death is induced by the mutation, whereas others have ruled out cell death induction18,19,20. Some investigations have reported that the cell death was necrosis, whereas others have reported it was apoptosis19,20. It has been shown that elevated extracellular Ca2+ concentrations drive the hemichannels into their closed state24. However, a number of reports did not mention exact Ca2+ concentrations in their experiments. The present study characterizes the effects of three KID syndrome-causative Gjb2 mutations (Cx26-G12R, -G45E and -D50N) on hemichannel activities, cell death and immune responses of the cells with information on the Ca2+ concentrations for each experiment. To more accurately elucidate the roles of mutant Cx26 proteins in KID syndrome pathogenesis, we analyzed the cells by three-dimensional (3D) imaging. In addition, dye uptake experiments reported in the literature employed hemichannel blockers, carbenoxolone (CBX) and flufenamic acid16,25. In the present study, we used 18α-Glycyrrhetinic acid (AGA) as an additional hemichannel blocker.
Results
Lethality of cells transfected with the Gjb2 mutations Cx26-G12R or Cx26-G45E
To examine the effects of the KID syndrome-associated Gjb2 mutations Cx26-G12R and -G45E on the intracellular localization of Cx26, HeLa (human cervical carcinoma) cells lacking endogenous gap junctions were transiently transfected with pIRES2-AcGFP1 Cx26-WT (wild-type), -G12R or -G45E-FLAG constructs (pIRES2-AcGFP1 Gjb2 WT, c.34 G > C or c.134 G > A-FLAG constructs). In the first series of experiments, we incubated the cells in Dulbecco’s Modified Eagle Medium (DMEM) + fetal bovine serum (FBS), which contained 1.9 mM Ca2+, at transfection. The transfected cells were easily recognized by the presence of green fluorescence from enhanced green fluorescent protein (eGFP). Cells transfected with Gjb2 c.34 G > C (Cx26-G12R) or c.134 G > A (Cx26-G45E) constructs started to detach from the culture slides at 48 h after transfection, and all the transfected cells died within approximately 3–4 days under the condition of 1.9 mM Ca2+ concentration. No gap junction plaques were observed between neighboring cells expressing Cx26-G12R or Cx26-G45E.
Intracellular localization of Cx26-WT and Cx26-D50N mutant proteins
We produced HeLa cells transiently transfected with pIRES2-AcGFP1 Cx26-WT constructs (pIRES2-AcGFP1 Gjb2 WT-FLAG constructs) and HeLa cells transiently transfected with Cx26-D50N-FLAG constructs (pIRES2-AcGFP1 Gjb2 c.148 G > A-FLAG constructs). We incubated the cells in DMEM + FBS, which contained 1.9 mM Ca2+, at transfection. Unlike the cells transfected with Gjb2 c.34 G > C (Cx26-G12R) or c.134 G > A (Cx26-G45E), the HeLa cells with Gjb2 WT (Cx26-WT) or c.148 G > A (Cx26-D50N) were able to proliferate even after transfection under the condition of 1.9 mM Ca2+ concentration. Immunofluorescent staining with ant-FLAG antibody (Cx26-FLAG staining) demonstrated that cells expressing Cx26-WT or Cx26-D50N were able to synthesize Cx26 proteins (Fig. 1, Supplementary Videos S1–S4). Further, Cx26 proteins were localized to the plasma membrane, and gap junction plaques were formed at the cell-to-cell contact zones between adjacent cells (Fig. 1, blue arrows, Supplementary Videos S1–S4). To clearly demonstrate the intracellular location of Cx26-WT and Cx26-D50N proteins, co-labeling with an anti-Cx26-FLAG antibody and an antibody to TGN46, which is a marker for the trans-Golgi network (TGN), or double staining with an anti-Cx26-FLAG antibody and wheat germ agglutinin (WGA) for plasma membrane staining were performed (Fig. 1 Supplementary Videos S1–S4). There was no overlap of Cx26 and TGN46 signals in cells expressing Cx26-WT or -D50N (Fig. 1A,B, blue arrowheads, Supplementary Videos S1 and S2). Furthermore, Cx26-FLAG and WGA co-staining showed that Cx26-FLAG staining overlapped with WGA staining in the cell membrane area without cell-to-cell contact and verified that Cx26-WT and -D50N were localized to the plasma membrane under the condition of 1.9 mM Ca2+ concentration (Fig. 1C,D, purple arrowheads, Supplementary Videos S3 and S4). In contrast, gap junction plaques showed no overlap of Cx26-FLAG with WGA (Fig. 1C,D, blue arrows, Supplementary Videos S3 and S4). WGA labels glycoproteins or glycolipids on the outer surface of the cell membrane26. Completely built gap junction plaques consist of a compact assembly of connexin molecules lacking surface glycoproteins and glycolipids. Thus, WGA cannot bind to the gap junction plaque. These findings clearly indicate that Cx26-WT and Cx26-D50N expressed in the HeLa cells were localized to the plasma membrane, but not to the Golgi apparatus, and that WGA was unable to access the gap junction plaques consisting of Cx26-WT and Cx26-D50N.
High extracellular Ca2+ concentration rescues cells producing Cx26-G12R mutants and those producing Cx26-G45E mutants
We tested whether cell death due to Cx26-G12R mutants or Cx26-G45E mutants could be abolished by increased extracellular Ca2+ concentration (3.8 mM). The cell death induced by the Gjb2 mutation Cx26-G12R and that induced by the Gjb2 mutation Cx26-G45E were prohibited by the high extracellular Ca2+ concentration (3.8 mM). Cells transfected with Cx26-G12R or Cx26-G45E mutant DNA constructs showed no overlap of Cx26-FLAG and TGN46 (Fig. 2A,B, blue arrowheads, Supplementary Videos S5 and S6) under the condition of high extracellular Ca2+ concentration. Under the high extracellular Ca2+ condition, HeLa cells with Cx26-G12R or Cx26-G45E also formed gap junction plaques without WGA co-staining between adjacent cells (Fig. 2, blue arrows, Supplementary Videos S5–S8). Hemichannels co-stained with WGA were also detected (Fig. 2C,D, purple arrowheads, Supplementary Videos S7 and S8). These results suggest that both Cx26-G12R-expressing cells and Cx26-G45E-expressing cells were rescued by the high extracellular Ca2+ concentration and that the Cx26 proteins formed gap junction plaques and hemichannels in the rescued cells, similarly to gap junction plaques and hemichannels in the cells transfected with Cx26-WT or Cx26-D50N mutants. Consequently, cells carrying Cx26-G12R or Cx26-G45E were judged to be insufficiently healthy for further mutant protein localization studies and for gene expression profiling under the condition of physiological Ca2+ concentration.
Altered activities of Cx26-D50N hemichannels
We determined the effects of Cx26-D50N in mammalian cell lines with a fluorescent dye uptake assay using neurobiotin (NB) (Fig. 3). Under Ca2+-free conditions, the mean fluorescent intensity of NB in cells with Cx26-WT or Cx26-D50N hemichannels was three times as high as that in negative control cells (p < 0.01). Under the conditions of physiological Ca2+ concentration (1.2 mM), NB uptake was almost the same in cells with Cx26-WT as in the negative control cells, but NB uptake by Cx26-D50N-expressing cells was about 1.7 times as large as those by cells with Cx26-WT and negative control cells (p < 0.01) (Fig. 3A).
NB dye uptakes by the cells with Cx26-WT or Cx26-D50N under the condition of 1.2 mM Ca2+ concentration were less than those under the Ca2+-free conditions (p < 0.01). These results suggest that both normal hemichannels of Cx26-WT and aberrant hemichannels of Cx26-D50N had similar activities under the Ca2+-free conditions, but that aberrant hemichannel activities were aggravated under the condition of physiological Ca2+ concentration.
To further verify the formation of abnormal hemichannels in the plasma membrane, dye uptake studies were performed with the presence of hemichannel blockers, CBX and AGA (Fig. 3B,C). Under the Ca2+-free condition, the treatment of cells with 100 μM CBX or AGA for 20 min reduced the levels of dye uptake in both cells producing Cx26-WT and Cx26-D50N compared to their counterparts without CBX or AGA treatment, respectively (p < 0.01) (Fig. 3B). Under the condition of physiological Ca2+ concentration (1.2 mM), treatments of cells with 100 μM CBX or AGA for 20 min resulted in a 40% reduction in the levels of dye uptake (mean fluorescent intensities) in Cx26-D50N-expressing cells compared to their counterparts without CBX or AGA treatment, respectively (p < 0.01) (Fig. 3C). In contrast, cells producing Cx26-WT with or without hemichannel blocker treatment showed almost the same levels of dye uptake (mean fluorescent intensities). These findings suggest that the increase in the uptake of NB into cells was mediated by aberrant hemichannels consisting of Cx26-D50N.
Cx26-D50N mutant down-regulates expression of genes involved in immune responses by keratinocytes
To identify down-regulated genes in the HaCaT cells (human skin keratinocytes) producing Cx26-D50N, we analyzed data from gene expression profiling using the Clariom S array. Using a minimum fold change of 2.5, we selected 69 down-regulated genes. We evaluated these genes by using the functional annotation chart of DAVID Bioinformatics Resources 6.8 (https://david.ncifcrf.gov/). We initially chose 6 terms involved in immunological processes: “immunity”, “positive regulation of T cell proliferation”, “inflammatory response”, “innate immune response”, “TNF signaling pathway” and “defense response to bacterium”. Under these terms, we found 16 genes associated with immune function (IL23R, FCN1, CLEC4E, IFNL1, IFNL3, BIRC3, IL1A, IL15, USP41, CD180, TAPBPL, HMHB1, CCL5, TLR5, FCAMR and USP41) out of the 69 differentially expressed genes (16/69 genes, 23%). Next, we evaluated these genes by using the functional annotation clustering of DAVID Bioinformatics Resources 6.8. We adopted an enrichment score of more than 1.98 and an adjusted p-value of less than 0.05 to select these down-regulated genes, and we chose 9/16 genes involved in immunological processes. Among these genes, we selected a total of 5 genes (IL15, CCL5, IL1A, IL23R, and TLR5) that have been reported in numerous papers in the past. We confirmed the down-regulation of mRNA expression of those genes by real-time PCR (Fig. 4) and concluded that Cx26-D50N expression resulted in the down-regulated mRNA expression of IL15, CCL5, IL1A, IL23R and TLR5.
Discussion
Elucidation of the effects of KID syndrome-causative Cx26 mutations might provide clues on how Cx26 functions in normal epidermal homeostasis and on the pathomechanisms of disease phenotypes in KID syndrome patients. In the present study, we examined how three Gjb2 mutants (Cx26-G12R, -G45E and -D50N) causative of KID syndrome affected the formation and function of the hemichannels and gap junctions in transfected HeLa cells. In addition, we analyzed the cells by 3D imaging. In the 3D images, we are able to evaluate the molecular localization sites more accurately, although in 2D images we sometimes misunderstood the colocalization sites of target molecules.
GJB2 mutations causative of KID syndrome have been shown to induce elevated hemichannel activities22,27,28. In the present study, the Gjb2 mutations Cx26-G12R and Cx26-G45E led to increased hemichannel activity and induced cell death. The Gjb2 mutation Cx26-D50N induced high hemichannel activity, but showed no cellular lethality. The cell death induced by the Gjb2 mutation Cx26-G12R and that induced by the Gjb2 mutation Cx26-G45E were rescued by the addition of extracellular Ca2+. It was previously shown that cells with GJB2 mutations are rescued from cell death by the introduction of Ca2+ to the extracellular media during incubation, although cells carrying different GJB2 mutations showed different reactions to high extracellular Ca2+ levels28. It is known that elevated extracellular Ca2+ drives the hemichannels into their closed state24. The high extracellular Ca2+ condition prohibited cell death induced by the GJB2 mutant Cx26-G12R and that induced by the GJB2 mutant Cx26-G45E25,27,28.
Regarding the hemichannel current, the cells carrying the GJB2 mutation Cx26-G12R responded more quickly and completely to the high Ca2+ concentration switch than did the cells with the GJB2 mutation Cx26-D50N28. Elevation of the external Ca2+ concentration reduced the amplitude of hemichannel currents by shifting the voltage activation curve of the channels to more positive potentials29. This indicates that different activation voltages resulting from the mutations might cause higher hemichannel activity leading to cellular lethality. The Cx26 mutant Cx26-D50N was previously reported to induce elevated membrane currents in Xenopus oocytes as measured electrophysiologically30. Cells expressing the Cx26-D50N showed abnormal hemichannel activity and increased cell death in the absence of elevated extracellular Ca2+28. Recently, several studies have used highly sophisticated methodologies to investigate the calcium gating of Cx26-D50N hemichannels. Lopez et al.30,31,32 reported that extracellular Ca2+ destabilizes the open state of human Cx26 hemichannels by disrupting a salt bridge interaction between residues D50 and K61 located close to the extracellular entrance of the pore of the hemichannels. This open-state destabilization is thought to facilitate hemichannel closure30,31. A highly conserved electrostatic network located at the extracellular entrance of the pore is involved in the gating of hemichannels of all connexin types. Extracellular Ca2+ disrupts the open-channel form of this network, resulting in a closed conformation32. Another study by Helmuth et al.33 revealed that Q48 and D50 tightly interact and that disruption of this interaction activates hemichannel gating along the voltage axis. Further shifts in gating activation by extracellular Ca2+ persist even in the absence of the Q48-D50 interaction, but the shifts require an Asp (D) or Glu (E) at position 5033. This fact suggests an independent electrostatic mechanism of gate activation that significantly involves position 50. The difference of Cx26-D50N from Cx26-G12R and Cx26-G45E in terms of their in vivo and in vitro effects may due to the unique characteristics of D50. In the present study, hemichannel activity in Cx26-D50N was less responsive to changes in the extracellular Ca2+ concentration. Summarizing the results of hemichannel activities in the present study, we clearly demonstrated the formation of aberrant hemichannels by the KID syndrome-causative Gjb2 mutations Cx26-G12R, -G45E and -D50N. The present results further support the idea that abnormal hemichannel activities play an important role(s) in the pathogenesis of KID syndrome.
Hearing impairment-associated Cx26 mutants are roughly classified into two categories. Cx26 mutants in the first category are still localized to the cell membrane and form non-functional gap junctions. Cx26 mutants in the second category accumulate in the cytoplasm due to the abnormal trafficking25. The Cx26 mutants in this category localize within subcellular structures, including the ER, the ER-Golgi intermediate compartment and the Golgi apparatus34,35,36,37. In the present study, it was difficult to clarify the relationship between the Cx26 mutants and the trans-Golgi network. However, in the 3D images, none of the Cx26 mutants showed overlapping localization with TGN46 protein signals under the condition of high extracellular Ca2+ levels. This indicates that the Gjb2 mutants Cx26-G12R, -G45E and -D50N can be classified into the first category. Most of the mutations associated with KID syndrome have shown to cause aberrant hemichannel activities, leading to the altered regulation of molecular exchanges through the plasma membrane22,25,27,28. As is true for the many characterized cell lines from KID syndrome patients16,25, in the present study, cells with Cx26 constructs with the mutation Cx26-D50N showed increased uptake of NB fluorescent dye, and the increased uptake was abolished by the hemichannel blockers CBX and AGA. This suggests that aberrant hemichannel activities are involved in the pathomechanisms of KID syndrome phenotypes due to the Cx26-D50N mutation.
Patients with KID syndrome are at high risk for neoplastic complications or cutaneous infections such as those of Candida albicans and Trichophyton rubrum6. Although the genetic defect of KID syndrome has been identified, the mechanisms behind the high incidence of neoplastic complications and fungal infections in KID syndrome are poorly understood. Increased risk of malignant tumors and chronic infections in KID syndrome is likely attributable to impaired epithelial barrier function or defective immune function38. Regarding immune function in KID syndrome patients, some studies have reported it to be normal39,40, but others have showed immune dysregulation41 or have suggested primary systemic immunodeficiency3,42. In the present study, we determined that human keratinocytes expressing the Cx26-D50N mutant show down-regulated expression of IL15, CCL5, IL1A, IL23R and TLR5, compared with keratinocytes expressing Cx26-WT. Interleukin-15 (IL-15) exhibits biological activities similar to those of interleukin-2 and enhances the proliferation of CD8+ cytotoxic T cells and natural killer cells, which in turn eliminate tumor cells43,44,45,46,47,48,49. Chemokine C-C motif ligand 5 (CCL5) plays an important role in recruiting various leukocytes, including T cells, macrophages, eosinophils, and basophils, to inflammatory sites. In collaboration with certain cytokines released from T cells, CCL5 also activates natural killer cells to C-C chemokine-activated killer cell and induces their proliferation50. Interleukin-1α (IL1α) is produced by cells of various types, including activated macrophages, keratinocytes, stimulated B lymphocytes, and fibroblasts, and it is a potent mediator of inflammation and immune reactions51. In humans, high levels of Interleukin-23 receptor (IL-23R) expression are detected on activated/memory T cells, NK cells, macrophages, dendritic cells and monocytes. IL-23 and Interleukin-12 (IL-12) share a common subunit in their receptor complex. The receptor complex is a heterodimer made up of 2 subunits, IL-23R and IL-12β152. Stimulation of the receptor complex activates janus activating kinase 2 (JAK2) and tyrosine kinase 2 (TYK2), resulting in phosphorylation of the receptor complex, and the formation of docking sites for signal transducers and activators of transcription (STATs) 1, 3, 4 and 5. The STATs are subsequently dimerized, phosphorylated and translocated into the nucleus, activating target genes53. Importantly, the phosphorylation of STAT4 is essential for increasing interferon (IFN) γ production and the subsequent differentiation of Th1 cells, whereas STAT3 is important for the development of interleukin 17-producing helper T cells (Th17 cells)54,55. Overall, this process orchestrates the cytokine cascade, activating the necessary immune cells involved in the eradication of any pathogenic/antigenic challenge.
Toll-like receptors (TLRs) provide efficient and immediate immune responses to bacterial, fungal, and viral infections by recognizing diverse molecules released from them56. One study reports that an Asian KID syndrome patient with fungal infection expressed only a lower level of TLR2 mRNA57. The present results clearly indicate that keratinocytes expressing the Cx26-D50N mutant show down-regulated expression of important molecules involved in the epidermal immune responses including IL-15, CCL5, IL-1α, IL-23 receptor and TLR5. We speculate that the down-regulation might cause immunodeficiency in the epidermis of KID syndrome due to the Cx26-D50N mutant, resulting in the malignant tumors and chronic infections seen in the patients.
Observations of 2-dimensional plane images are insufficient to clarify the intracellular localization of Cx26 proteins and the formation sites of hemichannels. In the present study, we analyzed the 3D images of cells expressing WT and mutant Cx26 molecules and were able to demonstrate clearly the intracellular localization of Cx26 proteins and hemichannel formation sites.
In conclusion, we clearly demonstrated that aberrant hemichannels form due to the KID syndrome-causative Gjb2 mutations Cx26-G12R, -G45E and -D50N. Our findings further support the idea that abnormal hemichannel activities are involved in the pathogenesis of KID syndrome. In addition, we revealed that the expressions of IL15, CCL5, IL1A, IL23R and TLR5 are down-regulated in keratinocytes expressing the Cx26-D50N mutation. These findings suggest that the immune deficiency of KID syndrome caused by Cx26-D50N mutation owes not only to skin barrier dysfunction, but also to the down-regulated expression of immune response-related genes in the keratinocytes.
Methods
Cell culture
Parental HeLa cells were grown as previously described58. The keratinocytes cell line HaCaT was kindly provided by N Fusenig (German Cancer Research Center, Heidelberg, Germany)59. HeLa cells that have no gap junction communication channel, and HaCaT cells were maintained in DMEM (Thermo Fisher Scientific, Waltham, Massachusetts, USA) supplemented with 10% FBS (Equitech-Bio Inc., Kerrville, Texas, USA) in a humidified chamber with 5% CO2 at 37 °C. This DMEM + FBS contained 2.0 mM Ca2+.
Construction of mouse Gjb2 mutant clones
The Gjb2 cDNA constructs pCMV-Gjb2 (WT, c.34 G > C, c.134 G > A and c.148 G > A)-FLAG-IRES2-AcGFP1 (Takara Bio Inc., Shiga, Japan) were produced as follows: Gjb2 (WT, c.34 G > C, c.134 G > A or c.148 G > A)-FLAG genes were synthesized artificially and subcloned into the Nhel/BamHI site in the pIRES2-AcGFP1 vector (Clontech, Mountain View, California, USA). The constructs were used for transfection experiments including immunocytochemical, dye uptake, microarray and functional studies targeting HeLa cells, which do not have any endogenous gap junctions. If products of transfected KID syndrome-causative mutations coexisted with other endogenous connexins, we were afraid that such coexistence might affect the interaction and functional properties of mutant Cx2617. We selected mouse Gjb2 mutations to minimize the influence of human endogenous Cxs.
Transfection experiments targeting HeLa Cells
Briefly, 1 day before transfection, cells were plated in 8-well glass slides (Thermo Fisher Science, Waltham, Massachusetts, USA) in DMEM + FBS (225 μl, Ca2+ concentration, 2.0 mM) and they were 70–95% confluent on the day of transfection. Lipofectamine 3000 reagent, plasmids, and OPTI-MEM medium (Life Technologies, California, USA) were brought to room temperature. DNA (total of 0.1 μg), Lipofectamine 3000 reagent (0.4 μl) and P3000 reagent (0.2 μl) were diluted in 5 μl of OPTI-MEM following the manufacturer’s protocol. Following 15 min of incubation at room temperature, the DNA, Lipofectamine and OPTI-MEM mixture (10 μl, Ca2+ concentration, 0 mM) was added to the cells drop by drop, and the cells were incubated at 37 °C for 48 h in the DMEM + FBS with DNA, Lipofectamine and OPTI-MEM mixture (Ca2+ concentration, 1.9 mM). The cells were then used for immunofluorescence staining or dye uptake assays.
Immunofluorescence staining
HeLa cells (2.0 × 104) were grown over glass coverslips in 8-well glass slides for immunofluorescent staining experiments. At 48 h post-transfection, the cells were fixed with 4% paraformaldehyde (PFA) for 15 min, washed twice with phosphate buffered saline (PBS), permeabilized with 0.25% Triton-X 100 (Wako, Tokyo, Japan) for 30 min, washed twice with PBS and blocked with 10% bovine serum albumin (BSA) for 30 min at 37 °C. The cells were then incubated overnight with M2 monoclonal mouse antibody against FLAG (Sigma-Aldrich, St. Louis, USA) diluted to 1:1000 at RT, washed twice with PBS followed by the application of tetra-methyl rhodamine isothiocyanate (TRITC)-conjugated rabbit polyclonal anti-mouse immunoglobulin antibody (Dako Cytomation, Glostrup, Denmark), diluted to 1:1000 and left for 45 min at 37 °C in the dark. After two more washings with PBS, coverslips were mounted with VECTORSHIELD mounting medium with DAPI (Vector laboratories, California, USA) on glass slides.
For co-immunofluorescent staining for TGN46, which is a marker for the trans-Golgi network, and for Cx26-FLAG proteins, the cells were incubated with primary antibodies (M2 monoclonal mouse antibody against FLAG (1:1000) and rabbit anti-TGN46 (1:500) (Abcam, Cambridge, UK)) for 2 h at RT. After two more washings with PBS, secondary antibodies (goat polyclonal anti-mouse IgG antibody, Alexa Flour 350 (1:1000) (Invitrogen, Massachusetts, USA) and TRITC-conjugated swine polyclonal anti-rabbit immunoglobulins antibody (1:1000) (Dako Cytomation, Glostrup, Denmark)) were applied for 45 min at 37 °C in the dark. After two more washings with PBS, coverslips were mounted with VECTORSHIELD mounting medium (Vector laboratories, California, USA) on glass slides.
For co-labeling for rhodamine-labeled WGA and Cx26-FLAG, after blocking with 10% BSA, rhodamine-labeled WGA (5 mg/ml, Vector laboratories, California, USA) diluted 1:500 was applied to cells for 30 min at 37 °C. After two washings with PBS, the cells were incubated with primary antibodies (M2 monoclonal mouse antibody against FLAG (1:1000)) overnight at RT. After two more washings with PBS, secondary antibodies (goat polyclonal anti-mouse IgG antibody, Alexa Flour 350 (1:1000) (Invitrogen, Massachusetts, USA)) were applied for 45 min at 37 °C in the dark. After two more washings with PBS, coverslips were mounted with VECTORSHIELD mounting medium on glass slides.
Staining was verified using an A1R confocal laser scanning microscope system, TiE-A1R, (Nikon, Japan) with x40 and x100 oil-immersion objectives.
Dye uptake assays
HeLa cells (2.0 × 104) were grown over glass coverslips in 8-well glass slides for dye uptake assays with an NB tracer (NB, FW 322.8, Vector Laboratories). At 48 h post-transfection (Ca2+ concentration, 1.9 mM), the cells were washed with PBS and incubated with Ca2+-free medium or a medium with a physiological calcium concentration (1.2 mM Ca2+) for 20 min at 37 °C. The cells were then incubated with 0.5 mg/ml NB in the same Ca2+ concentration medium for 20 min at 37 °C22. Next, the cells were washed with DMEM containing 4.0 mM CaCl2 twice for 10 min and PBS once. The cells were fixed with 4% PFA for 15 min at room temperature. After being washed twice with PBS, the fixed cells were permeabilized with 0.25% Triton-X 100 for 30 min, washed twice with PBS, and blocked with 10% BSA for 30 min at 37 °C. Following the two washings with PBS, the cells were incubated with primary antibodies (mouse monoclonal anti-FLAGR M2 antibody (1:1000)) overnight at RT. After two more washings with PBS, TRITC-conjugated rabbit polyclonal anti-mouse immunoglobulins antibody (1:1000) and Alaxa Flour 350-conjugated Streptavidin (1:200) (Invitrogen, Massachusetts, USA) were applied for 45 min at 37 °C in the dark. After two more washings with PBS, images were acquired using the A1R confocal laser scanning microscope system with fixed exposure times. For treatments with carbenoxolone (CBX, Sigma-Aldrich, St Louis, USA) or 18α-Glycyrrhetinic acid (AGA, Sigma-Aldrich), the cells were initially incubated with calcium-free medium containing 100 μM CBX or AGA for 20 min, and then NB in the same medium was applied to the cells as described above.
Image analysis for signal intensity determination was performed with ImageJ software (NIH, Bethesda, USA). We selected 2 high-power view fields under the microscope. During image analysis, after the background in merged images of red and green channels was subtracted, the same parameters were applied to threshold the images for the measurement of blue signal intensities of fluorescence only in the GFP-positive cells16. Each experiment was performed at least twice.
Transfection experiments targeting HaCaT cells for microarray analysis
HaCaT cells were transfected using the Amaxa Cell Line Nucleofector Kit V (Lonza, Cologne, Germany) according to the manufacturer’s instructions. The cells were seeded on the plate and the medium was changed 3 h after seeding. At 8 h of incubation, the cells were subjected to microarray analysis and quantitative real-time reverse transcription (qRT)-PCR assays.
Microarray analysis
We isolated total RNA from the transfected HaCaT cells using the RNeasy Mini Kit (Qiagen, Hiden Germany). Whole-genome expression profiling was performed using Clariom S Array (Affymetrix, Santa Clara, California, USA). Differentially expressed genes were defined as those showing a 2.5-fold or greater change in expression between the cells transfected with Gjb2 WT constructs (Cx26-WT) and those transfected with the c.134 G > A constructs (Cx26-D50N) using the Affymetrix Transcriptome Analysis Console Ver 3.1.0.5 (Affymetrix). The list of down-regulated genes was analyzed using gene-set enrichment analyses from DAVID Bioinformatics Resources 6.8 (https://david.ncifcrf.gov/) in order to identify the functions of these genes. We used an enrichment score of more than 1.9 and an adjusted p-value of less than 0.05 to select these down-regulated genes.
qRT-PCR
We isolated total RNA from the transfected HaCaT cells using the RNeasy Mini Kit (Qiagen). We reverse-transcribed 250 ng total RNA using the Prime Script RT Reagent Kit (Takara, Shiga, Japan) according to the manufacturer’s instructions. The recovered cDNA was diluted 10-fold with DW for qRT-PCR. mRNA expression levels were measured by qRT-PCR using the Light Cycler System (Roche, Basel, Switzerland). The PCRs were set up in microcapillary tubes filled with 10 μL of reaction agents including 2.5 μL of diluted cDNA solution, and the PCR program was set according to the manufacturer’s instructions. The primers and probes used for qRT-PCR are listed in Supplementary Table 1. Each experiment was performed at least three times.
Statistical analyses
All results are expressed as mean (± standard deviation). In the dye uptake assay, we selected 2 high-power view fields under the microscope without any random sampling method and each experiment was performed at least twice. In the qRT-PCR analysis, each experiment was performed at least three times. Analysis of dye uptake samples and qRT-PCR samples was done by Student’s t-test. Statistical significance was shown as *p < 0.01, †p < 0.05.
References
Skinner, B. A., Greist, M. C. & Norins, A. L. The keratitis, ichthyosis, and deafness (KID) syndrome. Arch Dermatol 117, 285–289 (1981).
Caceres-Rios, H., Tamayo-Sanchez, L., Duran-Mckinster, C., de la Luz Orozco, M. & Ruiz-Maldonado, R. Keratitis, ichthyosis, and deafness (KID syndrome): review of the literature and proposal of a new terminology. Pediatr Dermatol 13, 105–113 (1996).
Gilliam, A. & Williams, M. L. Fatal septicemia in an infant with keratitis, ichthyosis, and deafness (KID) syndrome. Pediatr Dermatol 19, 232–236 (2002).
Miteva, L. Keratitis, ichthyosis, and deafness (KID) syndrome. Pediatr Dermatol 19, 513–516 (2002).
Zhang, X., He, Y., Zhou, H., Luo, Q. & Li, C. Severe ichthyosis-related disorders in children: response to acitretin. J Dermatolog Treat 18, 118–122, https://doi.org/10.1080/09546630601156348 (2007).
Coggshall, K. et al. Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications. J Am Acad Dermatol 69, 127–134, https://doi.org/10.1016/j.jaad.2012.12.965 (2013).
Richard, G. et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 70, 1341–1348, https://doi.org/10.1086/339986 (2002).
Kelly, J. J., Simek, J. & Laird, D. W. Mechanisms linking connexin mutations to human diseases. Cell Tissue Res 360, 701–721, https://doi.org/10.1007/s00441-014-2024-4 (2015).
Laird, D. W. The gap junction proteome and its relationship to disease. Trends Cell Biol 20, 92–101, https://doi.org/10.1016/j.tcb.2009.11.001 (2010).
Retamal, M. A. et al. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 27, 13781–13792, https://doi.org/10.1523/JNEUROSCI.2042-07.2007 (2007).
Sáez, J. C. et al. Cell membrane permeabilization via connexin hemichannels in living and dying cells. Exp Cell Res 316, 2377–2389, https://doi.org/10.1016/j.yexcr.2010.05.026 (2010).
De Vuyst, E. et al. Connexin hemichannels and gap junction channels are differentially influenced by lipopolysaccharide and basic fibroblast growth factor. Mol Biol Cell 18, 34–46, https://doi.org/10.1091/mbc.E06-03-0182 (2007).
Wang, N. et al. Paracrine signaling through plasma membrane hemichannels. Biochim Biophys Acta 1828, 35–50, https://doi.org/10.1016/j.bbamem.2012.07.002 (2013).
García, I. E. et al. Connexinopathies: a structural and functional glimpse. BMC Cell Biol 17(Suppl 1), 17, https://doi.org/10.1186/s12860-016-0092-x (2016).
Ogawa, Y. et al. Revertant mutation releases confined lethal mutation, opening Pandora’s box: a novel genetic pathogenesis. PLoS Genet 10, e1004276, https://doi.org/10.1371/journal.pgen.1004276 (2014).
Aypek, H., Bay, V. & Meşe, G. Altered cellular localization and hemichannel activities of KID syndrome associated connexin26 I30N and D50Y mutations. BMC Cell Biol 17, 5, https://doi.org/10.1186/s12860-016-0081-0 (2016).
García, I. E. et al. Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43. J Invest Dermatol 135, 1338–1347, https://doi.org/10.1038/jid.2015.20 (2015).
de Zwart-Storm, E. A. et al. Molecular analysis of connexin26 asparagine14 mutations associated with syndromic skin phenotypes. Exp Dermatol 20, 408–412, https://doi.org/10.1111/j.1600-0625.2010.01222.x (2011).
Press, E. R. et al. Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss. J Biol Chem 292, 9721–9732, https://doi.org/10.1074/jbc.M116.770917 (2017).
Terrinoni, A. et al. Connexin 26 (GJB2) mutations, causing KID Syndrome, are associated with cell death due to calcium gating deregulation. Biochem Biophys Res Commun 394, 909–914, https://doi.org/10.1016/j.bbrc.2010.03.073 (2010).
Donnelly, S. et al. Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis. Exp Dermatol 21, 592–598, https://doi.org/10.1111/j.1600-0625.2012.01521.x (2012).
Mese, G. et al. The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome. Mol Biol Cell 22, 4776–4786, https://doi.org/10.1091/mbc.E11-09-0778 (2011).
Jara, O. et al. Critical role of the first transmembrane domain of Cx26 in regulating oligomerization and function. Mol Biol Cell 23, 3299–3311, https://doi.org/10.1091/mbc.E11-12-1058 (2012).
Müller, D. J., Hand, G. M., Engel, A. & Sosinsky, G. E. Conformational changes in surface structures of isolated connexin 26 gap junctions. EMBO J 21, 3598–3607, https://doi.org/10.1093/emboj/cdf365 (2002).
Stong, B. C., Chang, Q., Ahmad, S. & Lin, X. A novel mechanism for connexin 26 mutation linked deafness: cell death caused by leaky gap junction hemichannels. Laryngoscope 116, 2205–2210, https://doi.org/10.1097/01.mlg.0000241944.77192.d2 (2006).
Chazotte, B. Labeling membrane glycoproteins or glycolipids with fluorescent wheat germ agglutinin. Cold Spring Harb Protoc 2011, pdb.prot5623, https://doi.org/10.1101/pdb.prot5623 (2011).
Gerido, D. A., DeRosa, A. M., Richard, G. & White, T. W. Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness. Am J Physiol Cell Physiol 293, C337–345, https://doi.org/10.1152/ajpcell.00626.2006 (2007).
Lee, J. R., Derosa, A. M. & White, T. W. Connexin mutations causing skin disease and deafness increase hemichannel activity and cell death when expressed in Xenopus oocytes. J Invest Dermatol 129, 870–878, https://doi.org/10.1038/jid.2008.335 (2009).
Ebihara, L. & Steiner, E. Properties of a nonjunctional current expressed from a rat connexin46 cDNA in Xenopus oocytes. J Gen Physiol 102, 59–74 (1993).
Lopez, W., Gonzalez, J., Liu, Y., Harris, A. L. & Contreras, J. E. Insights on the mechanisms of Ca(2+) regulation of connexin26 hemichannels revealed by human pathogenic mutations (D50N/Y). J Gen Physiol 142, 23–35, https://doi.org/10.1085/jgp.201210893 (2013).
Lopez, W., Liu, Y., Harris, A. L. & Contreras, J. E. Divalent regulation and intersubunit interactions of humanconnexin26 (Cx26) hemichannels. Channels (Austin) 8, 1–4, https://doi.org/10.4161/chan.26789 (2014).
Lopez, W. et al. Mechanism of gating by calcium in connexin hemichannels. Proc Natl Acad Sci USA 113, E7986–E7995, https://doi.org/10.1073/pnas.1609378113 (2016).
Sanchez, H. A., Villone, K., Srinivas, M. & Verselis, V. K. The D50N mutation and syndromic deafness: altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions. J Gen Physiol 142, 3–22, https://doi.org/10.1085/jgp.201310962 (2013).
Thomas, T., Telford, D. & Laird, D. W. Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J Biol Chem 279, 19157–19168, https://doi.org/10.1074/jbc.M314117200 (2004).
Marziano, N. K., Casalotti, S. O., Portelli, A. E., Becker, D. L. & Forge, A. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30. Hum Mol Genet 12, 805–812 (2003).
Su, C. C., Li, S. Y., Su, M. C., Chen, W. C. & Yang, J. J. Mutation R184Q of connexin 26 in hearing loss patients has a dominant-negative effect on connexin 26 and connexin 30. Eur J Hum Genet 18, 1061–1064, https://doi.org/10.1038/ejhg.2010.50 (2010).
Berger, A. C., Kelly, J. J., Lajoie, P., Shao, Q. & Laird, D. W. Mutations in Cx30 that are linked to skin disease and non-syndromic hearing loss exhibit several distinct cellular pathologies. J Cell Sci 127, 1751–1764, https://doi.org/10.1242/jcs.138230 (2014).
Harms, M., Gilardi, S., Levy, P. M. & Saurat, J. H. KID syndrome (keratitis, ichthyosis, and deafness) and chronic mucocutaneous candidiasis: case report and review of the literature. Pediatr Dermatol 2, 1–7 (1984).
Maintz, L. et al. Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad. Eur J Dermatol 15, 347–352 (2005).
Hazen, P. G. et al. Keratitis, ichthyosis, and deafness (KID) syndrome: management with chronic oral ketoconazole therapy. Int J Dermatol 31, 58–59 (1992).
Helm, K., Lane, A. T., Orosz, J. & Metlay, L. Systemic cytomegalovirus in a patient with the keratitis, ichthyosis, and deafness (KID) syndrome. Pediatr Dermatol 7, 54–56 (1990).
Haruna, K. et al. Severe form of keratitis-ichthyosis-deafness (KID) syndrome associated with septic complications. J Dermatol 37, 680–682, https://doi.org/10.1111/j.1346-8138.2010.00839.x (2010).
Lee, S. H., Shin, D. J. & Kim, S. K. Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells. Vet Immunol Immunopathol 165, 1–13, https://doi.org/10.1016/j.vetimm.2015.04.002 (2015).
Velásquez, S. Y. et al. Short Term Hypoxia Synergizes with Interleukin 15 Priming in Driving Glycolytic Gene Transcription and Supports Human Natural Killer Cell Activities. J Biol Chem 291, 12960–12977, https://doi.org/10.1074/jbc.M116.721753 (2016).
Suzuki, K. et al. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer. J Leukoc Biol 69, 531–537 (2001).
Borger, P., Kauffman, H. F., Postma, D. S., Esselink, M. T. & Vellenga, E. Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4+) T lymphocytes. Immunology 96, 207–214 (1999).
Dunne, J. et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 167, 3129–3138 (2001).
Bulfone-Paus, S. et al. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 9, 507–513, https://doi.org/10.1006/cyto.1996.0194 (1997).
Warren, H. S., Kinnear, B. F., Kastelein, R. L. & Lanier, L. L. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J Immunol 156, 3254–3259 (1996).
Soria, G. & Ben-Baruch, A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267, 271–285, https://doi.org/10.1016/j.canlet.2008.03.018 (2008).
Lord, P. C., Wilmoth, L. M., Mizel, S. B. & McCall, C. E. Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest 87, 1312–1321, https://doi.org/10.1172/JCI115134 (1991).
van de Vosse, E., Lichtenauer-Kaligis, E. G., van Dissel, J. T. & Ottenhoff, T. H. Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 54, 817–829, https://doi.org/10.1007/s00251-002-0534-9 (2003).
Lankford, C. S. & Frucht, D. M. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73, 49–56 (2003).
Ghilardi, N. et al. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol 172, 2827–2833 (2004).
Kikly, K., Liu, L., Na, S. & Sedgwick, J. D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18, 670–675, https://doi.org/10.1016/j.coi.2006.09.008 (2006).
Song, D. H. & Lee, J. O. Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev 250, 216–229, https://doi.org/10.1111/j.1600-065X.2012.01167.x (2012).
Ma, H., Liang, P., Chen, J., Feng, P. & Lai, W. Keratitis-ichthyosis-deafness syndrome accompanied by disseminated cutaneous fungal infection. J Dermatol 44, 1255–1261, https://doi.org/10.1111/1346-8138.13926 (2017).
Muro, Y., Ogawa, Y., Kato, Y. & Hagiwara, M. Autoantibody to thioredoxin reductase in an ovarian cancer patient. Biochem Biophys Res Commun 242, 267–271, https://doi.org/10.1006/bbrc.1997.7914 (1998).
Boukamp, P. et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106, 761–771 (1988).
Acknowledgements
This research was supported by AMED under Grant Numbers, JP17gm0910002 to M. A. and 17ek0917943501 to K. S. This research was also supported by JSPS KAKENHI Grant Numbers, JP15H04887 to M.A. and JP16K19717 to T. Takeichi. In addition, this research was supported by Lydia O’leary Memorial Pias Dermatological Foundation and Kanae Foundation for the Promotion of Medical Science to T. Takeichi.
Author information
Authors and Affiliations
Contributions
M.A. and K.S. supervised and conceived of the study. T. Taki conducted the experiment and data collection. T. Taki and T. Takeichi analyzed the data and created figures and tables. T. Taki wrote the main manuscript text with comments from M.A., K.S. and T. Takeichi.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Taki, T., Takeichi, T., Sugiura, K. et al. Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome. Sci Rep 8, 12824 (2018). https://doi.org/10.1038/s41598-018-30757-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-30757-3
- Springer Nature Limited